Provided by Tiger Trade Technology Pte. Ltd.

Protalix BioTherapeutics

3.14
+0.08002.61%
Post-market: 3.170.0314+1.00%18:49 EST
Volume:1.57M
Turnover:4.91M
Market Cap:252.52M
PE:45.46
High:3.19
Open:3.09
Low:3.06
Close:3.06
52wk High:3.19
52wk Low:1.32
Shares:80.42M
Float Shares:60.76M
Volume Ratio:1.10
T/O Rate:2.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0691
EPS(LYR):0.0367
ROE:12.64%
ROA:5.53%
PB:4.77
PE(LYR):85.67

Loading ...

Mar 30, 2021

Major Issues Report

8-K - Current report
Feb 23, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 16, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 12, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2020

Major Issues Report

8-K - Current report
Nov 24, 2020

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 29, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2020

Major Issues Report

8-K - Current report
Oct 23, 2020

Major Issues Report

8-K/A [Amend] - Current report
Oct 01, 2020

Major Issues Report

8-K - Current report
Sep 08, 2020

Major Issues Report

8-K - Current report
Aug 11, 2020

Major Issues Report

8-K - Current report
Aug 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2020

Major Issues Report

8-K - Current report
Jun 11, 2020

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans